» Articles » PMID: 38166694

Analysis of Influencing Factors on Long COVID in COVID-19 Patients Infected with Omicron Variant Three Months After Discharge: a Cross-sectional Study

Overview
Journal BMC Infect Dis
Publisher Biomed Central
Date 2024 Jan 3
PMID 38166694
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The purpose of this study is to analyze the influencing factors associated with Long-COVID in patients infected with Omicron variant of COVID-19 in Changchun City, Jilin Province, China three months after discharge in March 2022.

Methods: In this study, we conducted a telephone follow-up based on the real-world data collected from the Affiliated Hospital to Changchun University of Chinese Medicine, Changchun Tongyuan Shelter Hospital and Changchun Infectious Disease Hospital during the COVID-19 epidemic in Changchun in March 2022. We used the Global COVID-19 Clinical Platform Case Report Form for Post COVID condition as a follow-up questionnaire to collect the general information, past medical history, clinical symptoms, COVID-19 vaccine inoculation doses, and other relevant information to analyze the symptom characteristics of COVID-19 patients three months after discharge from the hospital and related factors affecting Long COVID.

Results: A total of 1,806 patients with COVID-19 were included in this study, 977 males and 829 females, with a mean age of 38.5 [30.0, 49.4] years, and the number of female patients suffering from Long COVID (50.87%) was greater than male patients (p = 0.023). The binary logistic regression analysis of factors influencing Long COVID showed that smoking history (OR (95%CI) = 0.551(0.425-0.714), p < 0.001, taking never smoking as a reference), allergy history (OR (95%CI) = 1.618 (1.086-2.413), p-value 0.018, taking no allergy as a reference), first symptoms (OR (95%CI) = 0.636 (0.501-0.807), p < 0.001, with no first symptoms as reference) and COVID-19 vaccine inoculation doses (OR (95%CI) = 1.517 (1.190-1.933), p-value 0.001, with ≤ 2 doses of COVID-19 vaccine inoculation doses as reference) constituted its influencing factors. The first symptoms of patients on admission mainly included fever (512 cases, 71.81%), cough (279 cases, 39.13%) and dry or itchy throat (211 cases, 29.59%). The most common symptoms of Long COVID were persistent fatigue (68 cases), amnesia (61 cases), insomnia (50 cases) and excessive sweating (50 cases).

Conclusion: The first symptoms on admission were predominantly fever, cough and dry or itchy throat. The most common symptoms of Long COVID were persistent fatigue, amnesia, insomnia and excessive sweating, and female patients were at a higher risk of Long COVID.

Citing Articles

Prevalence of and risk factors for long COVID following infection with the COVID‑19 omicron variant.

Moritani I, Yamanaka K, Nakamura T, Tanaka J, Kainuma K, Okamoto M Med Int (Lond). 2025; 5(2):17.

PMID: 39927297 PMC: 11803340. DOI: 10.3892/mi.2025.216.


Characterization and clinical outcomes of outpatients with subacute or chronic post COVID-19 cough: a real-world study.

Yao C, Cheng D, Yang W, Guo Y, Zhou T PeerJ. 2024; 12:e18705.

PMID: 39677958 PMC: 11645979. DOI: 10.7717/peerj.18705.

References
1.
Chen J, Wang R, Gilby N, Wei G . Omicron Variant (B.1.1.529): Infectivity, Vaccine Breakthrough, and Antibody Resistance. J Chem Inf Model. 2022; 62(2):412-422. PMC: 8751645. DOI: 10.1021/acs.jcim.1c01451. View

2.
Puntmann V, Carerj M, Wieters I, Fahim M, Arendt C, Hoffmann J . Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020; 5(11):1265-1273. PMC: 7385689. DOI: 10.1001/jamacardio.2020.3557. View

3.
Munblit D, Bobkova P, Spiridonova E, Shikhaleva A, Gamirova A, Blyuss O . Incidence and risk factors for persistent symptoms in adults previously hospitalized for COVID-19. Clin Exp Allergy. 2021; 51(9):1107-1120. PMC: 8444748. DOI: 10.1111/cea.13997. View

4.
Rao S, Lee G, Razzaghi H, Lorman V, Mejias A, Pajor N . Clinical Features and Burden of Postacute Sequelae of SARS-CoV-2 Infection in Children and Adolescents. JAMA Pediatr. 2022; 176(10):1000-1009. PMC: 9396470. DOI: 10.1001/jamapediatrics.2022.2800. View

5.
Ballering A, van Zon S, Olde Hartman T, Rosmalen J . Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study. Lancet. 2022; 400(10350):452-461. PMC: 9352274. DOI: 10.1016/S0140-6736(22)01214-4. View